Ken Griffin’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$102K Sell
34,382
-4,021
-10% -$11.9K ﹤0.01% 5267
2025
Q1
$87.6K Buy
38,403
+14,739
+62% +$33.6K ﹤0.01% 5201
2024
Q4
$90.2K Buy
+23,664
New +$90.2K ﹤0.01% 5245
2022
Q4
Sell
-2,971
Closed -$10K 6831
2022
Q3
$10K Buy
+2,971
New +$10K ﹤0.01% 5644
2021
Q4
Sell
-6,095
Closed -$73K 7325
2021
Q3
$73K Buy
6,095
+3,785
+164% +$45.3K ﹤0.01% 6000
2021
Q2
$62K Buy
+2,310
New +$62K ﹤0.01% 6141
2021
Q1
Sell
-5,699
Closed -$89K 6903
2020
Q4
$89K Buy
+5,699
New +$89K ﹤0.01% 4718
2020
Q3
Sell
-4,380
Closed -$99K 5376
2020
Q2
$99K Buy
4,380
+2,876
+191% +$65K ﹤0.01% 4243
2020
Q1
$27K Buy
1,504
+1,010
+204% +$18.1K ﹤0.01% 4624
2019
Q4
$58K Sell
494
-42
-8% -$4.93K ﹤0.01% 4367
2019
Q3
$49K Buy
+536
New +$49K ﹤0.01% 4364
2019
Q1
Sell
-1,255
Closed -$50K 5117
2018
Q4
$50K Buy
+1,255
New +$50K ﹤0.01% 4107
2018
Q3
Sell
-680
Closed -$19K 4803
2018
Q2
$19K Buy
+680
New +$19K ﹤0.01% 4060
2018
Q1
Sell
-541
Closed -$24K 4487
2017
Q4
$24K Sell
541
-81
-13% -$3.59K ﹤0.01% 3749
2017
Q3
$43K Buy
622
+117
+23% +$8.09K ﹤0.01% 3424
2017
Q2
$32K Buy
+505
New +$32K ﹤0.01% 3443
2015
Q4
Sell
-75
Closed -$10K 4356
2015
Q3
$10K Sell
75
-57
-43% -$7.6K ﹤0.01% 3886
2015
Q2
$20K Buy
+132
New +$20K ﹤0.01% 3582
2015
Q1
Sell
-83
Closed -$20K 4096
2014
Q4
$20K Buy
+83
New +$20K ﹤0.01% 3613
2014
Q3
Sell
-40
Closed -$20K 3783
2014
Q2
$20K Sell
40
-152
-79% -$76K ﹤0.01% 3260
2014
Q1
$106K Buy
+192
New +$106K ﹤0.01% 3050